Now more than ever, surgeons have the option to pick which robot they wish to use in surgery. Picking apart the reasons why reveals much similarity between the two surgical disciplines.

Newcomers to the market have increased the number of options available to both soft tissue and orthopedic surgeons when selecting a robot. Despite the two disciplines' differences, the factors considered by surgeons when picking a system are relatively similar.

Harsh economic conditions and increased competition are dictating that surgical robotics companies must quickly adopt new commercial strategies. In Vivo speaks to key players in the space to learn more.

Medtech Insight interviewed the CEO of Ceros Financial Services and its investment banking division, Ceros Capital Markets, about the firm’s considerations for funding early-stage medtechs, and outlook for medtech fundraising, in this uncertain economic climate.